Roche declares Phase 3 win for SERD in broad breast cancer population that eluded competitorsnews2025-09-22T10:29:20+00:00September 22nd, 2025|Endpoints News|
This year’s Endpoints 11 winners; Monarez testifies to Congress; Eli Lilly’s obesity pill lags; and morenews2025-09-20T10:00:58+00:00September 20th, 2025|Endpoints News|
MapLight prepares for IPO to back schizophrenia, Alzheimer’s drugnews2025-09-19T22:49:30+00:00September 19th, 2025|Endpoints News|
ACIP recommends that people consult a provider before getting Covid shotsnews2025-09-19T19:54:08+00:00September 19th, 2025|Endpoints News|
Merck wins approval of subcutaneous Keytruda, in bid to extend life of world’s top-selling drugnews2025-09-19T18:24:36+00:00September 19th, 2025|Endpoints News|
Regeneron’s Lynozyfic yields 100% response rate in small smoldering multiple myeloma studynews2025-09-19T17:15:16+00:00September 19th, 2025|Endpoints News|
CHMP recommends Novo’s weekly diabetes injection, Bayer’s menopause drugnews2025-09-19T15:03:25+00:00September 19th, 2025|Endpoints News|
CDC vaccine advisors shelve vote on hepatitis B birth dosenews2025-09-19T14:27:00+00:00September 19th, 2025|Endpoints News|
Endpoints 11 winner 2025: Chai Discovery aims to design drugs on the computernews2025-09-19T14:00:57+00:00September 19th, 2025|Endpoints News|
The 2025 winners of the Endpoints 11: Biotech’s most exciting startupsnews2025-09-19T14:00:57+00:00September 19th, 2025|Endpoints News|
